Kazia Therapeutics (KZIA) Total Debt (2018 - 2025)

Kazia Therapeutics' Total Debt history spans 5 years, with the latest figure at $253611.5 for Q2 2025.

  • For Q2 2025, Total Debt fell 94.06% year-over-year to $253611.5; the TTM value through Jun 2025 reached $253611.5, down 94.06%, while the annual FY2025 figure was $253611.5, 94.06% down from the prior year.
  • Total Debt reached $253611.5 in Q2 2025 per KZIA's latest filing, down from $4.3 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $5.7 million in Q2 2023 to a low of -$1.3 million in Q2 2022.
  • Average Total Debt over 4 years is $2.2 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Total Debt: surged 535.84% in 2023, then crashed 94.06% in 2025.
  • A 4-year view of Total Debt shows it stood at -$1.3 million in 2022, then soared by 535.84% to $5.7 million in 2023, then decreased by 25.72% to $4.3 million in 2024, then plummeted by 94.06% to $253611.5 in 2025.
  • Per Business Quant, the three most recent readings for KZIA's Total Debt are $253611.5 (Q2 2025), $4.3 million (Q2 2024), and $5.7 million (Q2 2023).